Cue Biopharma, Inc. (CUE)

USD 1.07

(0.94%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 61.53 Million 91.28 Million 83.4 Million 99.53 Million 71.6 Million 45.36 Million
Total Current Assets 51.45 Million 77.18 Million 68.46 Million 87.52 Million 61.02 Million 40.61 Million
Cash And Short Term Investments 48.51 Million 76.28 Million 64.37 Million 84.86 Million 44.29 Million 39.21 Million
Cash and Cash Equivalents 48.51 Million 51.61 Million 64.37 Million 74.86 Million 44.29 Million 20.8 Million
Short Term Investments - 24.67 Million - 10 Million 15.11 Million 18.41 Million
Net Receivables 1.69 Million 57.25 Thousand 3.14 Million 1.41 Million 754.89 Thousand -
Inventory 1.00 1.00 1.00 - 15.11 Million -
Other Current Assets 1.24 Million 841.21 Thousand 954.79 Thousand 1.24 Million 860.1 Thousand 1.34 Million
Total Non-Current Assets 10.07 Million 14.09 Million 14.93 Million 12 Million 10.58 Million 4.75 Million
Net PPE 7.11 Million 10.7 Million 11.92 Million 8.88 Million 7.18 Million 2.78 Million
Good Will And Intangible Assets - - - - 11.66 Thousand -
Good Will - - - - - -
Intangible Assets - - - - 11.66 Thousand -
Long-Term Investments 151 Thousand 150 Thousand 150 Thousand 150 Thousand 150 Thousand 150 Thousand
Tax Assets - - - - -161.66 Thousand -
Other Non Current Assets 2.8 Million 3.24 Million 2.86 Million 2.97 Million 3.39 Million 1.82 Million
Other Assets - - - - - -
Total Liabilities 24.44 Million 25.6 Million 17.9 Million 20.62 Million 17.02 Million 11.39 Million
Total Current Liabilities 17.08 Million 11.54 Million 12.78 Million 16.31 Million 11.65 Million 6.21 Million
Account Payables 3.5 Million 2.73 Million 2.59 Million 2.07 Million 882.66 Thousand 2.03 Million
Tax Payables - - - - - -
Short Term Debt 7.33 Million 5.26 Million 4.93 Million 4.77 Million 4.44 Million -
Deferred Revenue 2.11 Million - 645.34 Thousand 6.68 Million 4.09 Million 2.01 Million
Other Current Liabilities 4.13 Million 3.55 Million 4.61 Million 2.78 Million 2.22 Million 2.16 Million
Total Non Current Liabilities 7.36 Million 14.05 Million 5.12 Million 4.3 Million 5.36 Million 5.17 Million
Long-Term Debt 4.2 Million 14.05 Million 5.12 Million 2.36 Million 1.34 Million -
Deferred Revenue Non Current - - - 1.93 Million 4.01 Million 5.17 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 3.16 Million - - 1.93 Million 4.01 Million -
Other Liabilities - - - - -113.00 -
Total Equity 37.08 Million 65.68 Million 65.49 Million 78.91 Million 54.58 Million 33.97 Million
Stock Holders Equity 37.08 Million 65.68 Million 65.49 Million 78.91 Million 54.58 Million 33.97 Million
Common Stock 47 Thousand 43.04 Thousand 32.2 Thousand 30.35 Thousand 26.56 Thousand 20.69 Thousand
Retained Earnings -301.19 Million -250.45 Million -197.44 Million -153.28 Million -108.5 Million -71.8 Million
Accumulated other comprehensive income - -95.87 Thousand - 7131.00 -10.32 Thousand -10.95 Thousand
Common Stock Equity 37.08 Million 65.68 Million 65.49 Million 78.91 Million 54.58 Million 33.97 Million
Capital Lease Obligation 3.16 Million 9.31 Million 10.05 Million 7.14 Million 5.79 Million -
Total Investments 151 Thousand 24.67 Million 150 Thousand 10 Million 15.11 Million 18.41 Million
Total Debt 14.69 Million 19.31 Million 10.05 Million 7.14 Million 5.79 Million -
Net Debt -33.81 Million -32.29 Million -54.31 Million -67.71 Million -38.49 Million -20.8 Million

Balance Sheet Charts